1Ebinam E, Steibery SM, Mulsine JL, et al.Relationship of p53 overexpression and upregulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer[J].Cancer Res,1994,54(10):2496-2503.
2Yu CCW, Fletcher CDM, Newman P,et al. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumors[J]. Journal of Pathology,1992,166(1):1
3Hall PA, Levison DA, Woods AL,et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms[J].Journal of Pathology, 1990, 162(1):285-287.
4Zhu Q,Tipoe GL,White FH.Proliferative activity as detected by immunostaining with ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland[J].Anal-Quant-Cytol-Histol,1999,21(4):336-342.
5Mukhopadhyay D,Tsiokas L, Sukhatme VP,et al.Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression[J].Cancer Res,1995,55(21):6161-6165.
6Levine AJ,Peny ME,Chang A,et al.The role of the p53 tumor supress gene in tumourigen[J].Br J Cancer,1994,69(1):409-416.
7Cuningham J,Last JA,Schaid DJ,et al.Expression of p53 and P17 allelic loss in colorecatal carcinoma[J].Cancer Res,1992,52(2):649-652.
8Cho KJ,Lee YS.Proliferating cell nuclear antigen and c-erB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands[J].Head-Neck,1999;21(5):414-419.
9EI-Deiry WS ,Harper JW, O′coonnor PM, et al. WAF1/CIP1 is induce in p53-mediated G1 arrest and apoptosis[J]. Cancer Res, 1994,54:1169-1176.
10Yang Y, Forslun A, Remotti H,et al. p53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection[J]. Cancer,2001,91(4):727-736.
